Tabcin Capsule, Liquid Filled
FDA Label NDC 69729-836

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Opmx Llc for the product Tabcin (NDC 69729-836). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients (in each softgel), uses, do not use:, ask a doctor before use if you have:, stop use and ask a doctor if:, if pregnant or breast-feeding:, overdose warning:, directions:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.